The molecular principles that lead to chronic pancreatitis are incompletely understood. Trypsin(ogen) plays a key role in the development of pancreatitis. Since the production of trypsin(ogen) by acinary pancreatic cells is paralleled by the expression of vigilin we hypothesised that vigilin may be involved in the onset of pancreatitis. Vigilin is a ubiquitous protein and has apparently high affinity to RNA. In the present study experimental pancreatitis was induced in male rats by a single intravenous application of dibutyltin dichloride (DBTC). Sections of rat pancreas were immunostained with an affinity-purified polyclonal antiserum against vigilin or trypsin(ogen). The changes in vigilin and trypsin(ogen) protein expression were determined by immunoblotting and subsequent sequence analysis of the amino acids. Induction of pancreatitis by DBTC caused alterations in the distribution and the amount of both vigilin and trypsin(ogen) as shown by immunohistochemical and immunoblot analysis. Furthermore we could demonstrate that anionic trypsinogen expression is up-regulated in DBTC-induced chronic pancreatitis. The obtained results suggest that vigilin as well as trypsin(ogen) are involved in the pathogenesis of pancreatitis and that the long-time DBTC-induced pancreatitis is a useful model for study of chronic pancreatitis.
Introduction
The molecular and cellular mechanisms of acute pancreatitis and progression to chronic pancreatitis are still not fully understood and they are the object of intensive research [1, 2] . In the past decade, several mutations have been identified that predispose through the enhancement of intrapancreatic trypsin activity to acute and chronic pancreatitis [3] [4] [5] .
Because studies on the pathogenetic mechanism in human pancreatitis are restricted by the limited availability of pancreatic tissue, we used the experimental model of chronic pancreatitis in rats induced by dibutyltin dichloride (DBTC). It is characterised by leukocyte and macrophage infiltration, activation of T-lymphocytes and subsequent development of pancreatic fibrosis [6] .
Trypsin seems to play an important role in the development of pancreatitis because it is a trigger enzyme in the activation of many other digestive proenzymes [7] . Furthermore Tando et al. [8] suggested that trypsinogen activation is likely to modulate signalling events in acinar cells in the initial phase of acute pancreatitis. Therefore we choose trypsin(ogen) for our investigations.
The production of trypsin(ogen) by cells of the exocrine pancreas is paralleled by the expression of the ubiquitous protein vigilin as demonstrated in vivo [9] and in vitro [10] . Vigilin is a 150 kDa protein containing 14 copies of the hnRNP K homology (KH) domain, is present in the nucleus and in the cytoplasm [11] , and has apparently high affinity to RNA [12, 13] . It is an essential protein in human cells [14] and preferentially expressed in cells with increased protein synthesis, for example in pancreatic acinar and diverse carcinoma cells [9, 10] . A specific down-regulation of vigilin translation affects the synthesis of two different classes of proteins, digestive enzymes of the pancreas, as well as structural proteins such as cytokeratines [15] .
Here we hypothesised that the RNA-binding protein vigilin may play a crucial role in the onset of pancreatitis since trypsinogen is involved in the pathogenesis of pancreatitis [7, 8] and we could demonstrate that trypsinogen expression coincided with vigilin expression [9, 10] . In the present study the animal model of DBTC-induced chronic pancreatitis was used to test this hypothesis.
Statistical methods and Experimental Procedures

Experimental pancreatitis
Pancreatic tissue was obtained from male rats (LEW-1W; Karlsburg; Germany) weighing 150-170 g. Experimental pancreatitis was induced as described [6] . Briefly, dibutyltin dichloride (DBTC; Sigma-Aldrich, Deisenhofen, Germany) was first dissolved in 100% ethanol (2 parts) and mixed with glycerol (3 parts). 8mg/kg body weight DBTC was injected into the tail vein. At 7, 14, 28 and 60 days after the application of DBTC or solvent, animals were sacrificed under pentobarbital anaesthesia by cervical dislocation.
Immunohistochemical procedures
Immunohistochemical investigations were performed on 5μm thick cryostat sections of rat pancreatic tissue. Sections were immunostained with different antibodies. Primary antisera were directed against vigilin (FP-III, dilution 1:500 in PBS containing 0.1% bovine serum albumin) from rabbits [11] or trypsin (1:200 in PBS containing 0.1% bovine serum albumin) [9] . Specimens were incubated with the primary antibody overnight at 4
• C. After rinsing three times with PBS, slides were incubated with either FITC-labelled anti-rabbit IgG or Cy3-labelled anti-rabbit IgG for 1 hour at 37
• C. Slides were washed three times in PBS, embedded and analysed with a fluorescence microscope (Axioskop Zeiss, Germany). Rabbit preimmune serum (1:200) served as a background control.
Cell culture
For positive control of vigilin, an established cell line derived from a human epithelial larynx carcinoma (Hep-II, ATCC CCL 239) was grown in Iscoves medium (Sigma-Aldrich, Deisenhofen, Germany), supplemented with 10% fetal calf serum (Biochrom, Germany), 100U/ml penicillin, 100μg/ml streptomycin, 0,05 mg/ml l-ascorbic acid sodium salt (SigmaAldrich, Deisenhofen, Germany) and 2mM glutamine. For SDS-PAGE analysis 10 6 cells
were lysed for at least 1h in 50 μl of a lysis buffer consisting of 0,1% NaHPO 4 (w/v), 100mM phenylmethylsulfonyl fluoride and 0,5% Nonidet P-40. The cell extract was centrifuged (15000 × g, 10 min) and the supernatant was immediately used or stored at -70 • C.
Electrophoresis and immunoblotting of pancreatic extracts
For preparation of tissue homogenates, pancreata from rats were removed, washed in ice-cold 0,9% NaCl solution and frozen in liquid nitrogen. Samples were homogenised on ice in a glass homogeniser in a solution with Complete T M proteinase inhibitor cocktail tablets (Roche Diagnostic GmbH, Mannheim, Germany) and then centrifuged for 10 min at 3000 g. These supernatants were adjusted to identical protein concentrations using the Bradford assay [16] , heated for 10 min at 95
• C in Laemmli sample buffer in the presence of 0,1 mM β-mercaptoethanol and immediately separated by SDS-PAGE [17] . Using 7% polyacrylamide gels for vigilin and 10% polyacrylamide gels for trypsinogen detection, the presence of vigilin or trypsinogen was demonstrated by immunoblotting, using vigilin [11] or trypsinogen antibodies [9] . Preimmunization serum served as the background control. All Western blotting experiments were performed at least three times.
Protein sequence detection
The amino acid sequence analyses were performed by Edman-degradation with Procise 406 (Applied Biosystems) following the instructions of the manufacturer.
The FASTA program version 3.3t07 [18] was used to search protein databases for the detected protein sequence.
Each sample in this study was assessed in duplicate.
Results
Vigilin and trypsin distribution during experimental chronic pancreatitis induced by DBTC
It was demonstrated that vigilin was detected on the basal pole of the acinary cells whereas trypsin could be detected on the apical pole [9] . Immunohistological examinations of pancreatic tissue from untreated rats demonstrated an equal amount of vigilin (Fig. 1a) and trypsin (Fig. 1b) . Seven days after DBTC-exposure only a small staining of vigilin within the perinuclear areas of acinary cells (Fig. 1c) and a selective accumulation of trypsin (Fig. 1d) within the exocrine pancreas were detected. On day 60 after DBTC-treatment a similar distribution of vigilin and trypsin was seen ( Fig. 1e and 1f) , compared with the control pancreas ( Fig. 1a and 1b) but only within distinct areas.
Immunoblot analysis of vigilin and trypsin
The effect of DBTC treatment on the expression of the multi KH domain protein vigilin and trypsin in rat pancreatic tissue was analysed by immunoblotting. In line with the histological results immunoblotting experiments (Fig. 2a) indicated the presence of much more vigilin in the pancreatic supernatants of long time DBTC-exposed animals than in supernatants of 7 days incubated (compare lane 2 with lanes 4 and 5). Furthermore we observed an increase in vigilin expression with the duration of experiments.
During acute DBTC-induced pancreatitis trypsin(ogen) expression decreased compared to untreated rats (Fig. 2b , compare lane 1 with lane 2), but increased with the progression of the inflammatory process (Fig, 2b, compare lane 2 and 3 with lane 4) . On day 60 after induction of pancreatitis two new and unknown immunoreactive bands appeared on the trypsinogen immunoblot. To further analyse this phenomena, proteinsequencing was assessed and a protein with the following sequence could be detected: Phe Pro Leu Glu Asp Asp X Lys (FPLEDDXK). The sequence analysis showed 87,500% identity (Smith-Waterman score: 50) with rat pancreatic trypsin(ogen) 1 (P00762) also known as anionic trypsin(ogen).
Discussion
The molecular principles that are involved in the origin of chronic pancreatitis are incompletely understood. Investigations in humans are limited by the restricted availability of pancreatic tissue. Therefore, suitable animal models are necessary to study the dynamics of a complex pathogenetic process, which is characterised by the development of fibrosis and a progressive loss of parenchyma and pancreatic function. B,D,F) . Sections of rat pancreas were immunostained with an affinity-purified polyclonal antiserum against vigilin (FP-III) and trypsinogen, after induction of pancreatitis by dibutyltin dichloride (DBTC). Micrographs were obtained by fluorescence microscopy.
The animal model of chronic pancreatitis induced by DBTC is characterised by leukocyte infiltration with the development of pancreatic fibrosis [6] . Using this model we have now analysed the expression of the multi KH domain protein vigilin, as a marker of proteinsynthesis in comparison to expression of the digestive enzyme trypsin(ogen), which seems to play an important role in the development of pancreatitis. Here we could demonstrate by immunhistochemistry ( Fig. 1) as well as immunoblotting ( Fig. 2A) that the development of chronic pancreatitis in DBTC-treated rats is accompanied by an enhanced expression of the multi KH domain protein vigilin. In DBTC-treated rats the highest intensity of vigilin staining in pancreatic sections was found on the basal pole of cells (Fig. 1) , where the rough endoplasmic reticulum is mainly amassed [9] . This is in line with a molecular scenario, which implies that vigilin may function in certain stimulated conditions as a carrier for tRNA from the nucleus to the ribosomes as a point of translational machinery [19] , from where tRNAs possibly are passed onto the tRNA cycle [13] .
The increase in vigilin expression during the onset of chronic pancreatitis (Fig. 2a) was paralleled by enhanced trypsinogen expression (Fig. 2b) . Sixty days after induction of pancreatitis in rats we observed the appearance of new immunoreactive bands above the known trypsinogen on the immunoblot. Because all species investigated thus far produce two types of trypsinogen [20] , which differ in their isoelectric points and on electrophoresis at pH 8,6, we thought of them as isoenzymes. Using proteinsequencing we could detect anionic trypsinogen as new observed immunoreactive protein on the Western Blot.
Interestingly the synthesis of anionic proteins in rats, especially anionic trypsinogen, showed a progressive and significant increase after hormonal-hyperstimulation or when the animal was fed a protein-deficient diet [21] . Furthermore the up-regulation of anionic trypsinogen secretion is a characteristic feature of human pancreatic diseases [22] . Kimland et al. [23] described increases over normal of both anionic and cationic trypsin-like immunoreactivity in pancreatitis, with a proportionally greater increase in anionic than in cationic trypsin-like immunoreactivity.
Recently Kukor et al. [24] could show that trypsinogen activation was markedly diminished by an increased ratio of anionic trypsinogen under conditions that mimicked potential intracellular sites of pathological trypsinogen activation, such as the cytoplasm or acidic vesicles. In line with these results the enhanced anionic trypsin(ogen) production by acinary cells in chronic inflammatory processes after DBTC-treatment could be hypothetically a defensive mechanism of the exocrine pancreas, which decreases the chance for premature trypsinogen activation inside the pancreas but may maintain acceptable trypsin function in the duodenum.
In summary the presented results indicates that vigilin as well as trypsin(ogen) are involved in the pathogenesis of chronic pancreatitis. Furthermore we could demonstrate that anionic trypsinogen expression is up-regulated in DBTC-induced chronic inflammatory processes of the pancreas.
Whether or not vigilin, which is involved in cellular life sustaining processes, is a useful marker in pancreatic diseases has to be investigated in further studies.
